In the present study, we, for the first time, addressed the association of 3 novel circulating atherosclerosis-related lipid measurements including PCSK9, apoC3 and sdLDL-C with current dyslipidemias, to investigate the roles of these markers in determining potential lipid disorders. The gene discussed is PCSK9; the disease is atherosclerosis.